Skip to Content
Home > Wellness Resources > Health Library > Hypercalcemia (PDQ®): Supportive care - Patient Information [NCI]
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.
Hypercalcemia is too much calcium in the blood.
Calcium is one of the most important minerals in the body. Most calcium is in the bones, but some is in the blood. Calcium works in the body in the following ways:
The amount of calcium in the blood is normally controlled by hormones, the kidneys, and bone.
Parathyroid hormone and calcitrol, are hormones that help balance the calcium level in the body.
Normal, healthy kidneys help the body keep the amount of calcium it needs. The kidneys can remove large amounts of calcium from the blood and pass the extra calcium into the urine.
Most of the calcium in the body is in bone, but bone has only a small role in keeping the balance of calcium in the body.
Hypercalcemia (too much calcium in the blood) is a very serious problem in cancer patients.
When calcium is out of balance, the whole body is affected. If hypercalcemia is not treated, it will get worse and can lead to a coma and death. Early diagnosis and treatment are very important and can be lifesaving and may help you continue your cancer treatment and improve your quality of life.
Hypercalcemia (too much calcium in the blood) is the most common life-threatening complication of cancer occurring in 10% to 20% of adults and rarely in children. Hypercalcemia occurs most often in patients with:
A physical exam and lab tests are used to diagnose hypercalcemia.
The symptoms of hypercalcemia may occur slowly and may look like other illnesses, making it hard to diagnose. Early diagnosis and treatment may improve symptoms in a few days.
The following tests and procedures may be used:
Certain types of cancer and types of treatment may cause symptoms of hypercalcemia.
Some cancer cells cause the kidneys to return calcium to the blood after filtering it, instead of passing the extra calcium out of the body in urine. The kidneys keep making urine as they try to get rid of the extra calcium, and this causes the body to be dehydrated (not enough fluid). Dehydration can lead to the following:
Cancer patients are often too tired and weak to be as active as usual. Being inactive can increase calcium in the blood because bones release calcium when they are not being used. Also, some blood cancers make substances that cause bone to break down and release calcium into the blood.
Certain types of biologic therapy used for cancer treatment can also cause hypercalcemia. These therapies include the following:
Hormone therapy can also increase the amount of calcium in the blood.
Different patients may have different symptoms.
Hypercalcemia symptoms may differ between patients. They can appear slowly over time and may look like symptoms of cancer and other diseases. The most common symptoms of hypercalcemia include the following:
Hypercalcemia symptoms also depend on the organs that are affected.
Hypercalcemia can affect many organs of the body and symptoms depend on which organs are affected.
Calcium plays a major role in the way the central nervous system (the brain and spinal cord) works. Nervous system symptoms of hypercalcemia include the following:
Sometimes mental problems need treatment separate from the treatment for hypercalcemia.
Hypercalcemia affects normal heart rhythms. It can also make the heart more sensitive to certain heart medicines (such as digoxin). Calcium levels that are higher than normal can cause irregular heartbeats or a heart attack.
Increased stomach acid often occurs with hypercalcemia and may make the following symptoms worse:
Constipation may become worse if you are not drinking enough fluids.
Hypercalcemia causes the kidneys to make too much urine. This loss of fluid may lead to dehydration, which causes the following symptoms:
Patients with multiple myeloma often have kidney problems because of hypercalcemia. Kidney stones may form if hypercalcemia lasts a long time.
Hypercalcemia can be caused by cancer spreading to the bone or by bone loss. Bones may be painful or break.
Check NCI's list of cancer clinical trials for U.S. supportive and palliative care trials about hypercalcemia that are now accepting participants. The list of trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
Patients can learn to recognize early symptoms of hypercalcemia.
Hypercalcemia can be very serious and can cause death. It is important to learn how to recognize it early and manage it carefully. Patients at risk of hypercalcemia may be the first to notice its symptoms, such as fatigue. Ask your doctor if you are at risk for hypercalcemia and learn about the following:
Patients can take steps to prevent hypercalcemia.
To prevent hypercalcemia, patients can do the following:
Hypercalcemia causes the body to absorb less calcium from food. However, changing the diet to decrease calcium will not lower the amount of calcium in the blood.
Treatment depends on how severe the hypercalcemia is.
Hypercalcemia may be mild, moderate, or severe. Because hypercalcemia can be caused by cancer itself, treatment for hypercalcemia will depend on how well the cancer treatment is working.
Severe hypercalcemia should be treated right away. Less severe hypercalcemia is treated based on the symptoms. The treatment is working if the symptoms of hypercalcemia disappear and the level of calcium in the blood decreases.
Treatment that decreases the amount of calcium in the blood usually:
After calcium levels return to normal, urine and blood samples will be checked often to make sure the treatment is still working.
Patients with mild hypercalcemia may not have any symptoms and usually do not need agressive treatment. If you have no symptoms of hypercalcemia and your cancer responds well to anticancer treatment, treatment for hypercalcemia may include:
If you have symptoms of hypercalcemia or your cancer is not expected to respond quickly to treatment, treatment for the hypercalcemia may include the following:
Moderate to severe hypercalcemia.
Treatment for moderate to severe hypercalcemia includes the following:
Replacing fluids is the first and most important step in treating moderate or severe hypercalcemia. This will not lower blood calcium to normal levels in all patients, but fluid replacement will improve symptoms such as confusion, nausea, and vomiting.
If cancer treatment cannot be started right away, then drugs to lower the calcium levels are used to control the hypercalcemia. The following drugs help stop the breakdown of bone and the release of calcium into the blood:
Dialysis may be needed for patients with kidney failure.
Some patients may need medicine to manage confusion and other psychological symptoms.
Mental changes may take some time to get better, even after calcium levels return to normal. Usually, treatment of hypercalcemia will stop delirium, agitation, and mental changes, but some patients may need other medicines to treat these symptoms. (See the PDQ summary on Cognitive Disorders and Delirium for more information.)
Lethargy (feeling sluggish) is often a symptom of hypercalcemia. Family members (and sometimes medical staff) may think lethargy is depression until the actual cause is found. Most patients with lethargy will show little energy or interest in life. However, patients with lethargy will not have symptoms of depression (such as hopelessness, helplessness, guilt, worthlessness, or thoughts of suicide). It is important to know the difference between depression and lethargy so that the right treatment is given.
The decision to treat hypercalcemia depends on the treatment goals of the patient.
Hypercalcemia can make it hard to think clearly. Your choices about cancer care and treatment should be made when you are clearly able to decide for yourself. Untreated hypercalcemia will get worse and cause loss of consciousness and coma. Some patients who have advanced terminal cancer and are no longer getting treatment for the cancer may choose not to be treated for hypercalcemia.
Supportive care can comfort patients who are terminally ill.
When the cancer can no longer be treated, supportive care for hypercalcemia may include the following:
Supportive care can also help the family.
Supportive care can also comfort family members who may become upset by the changes hypercalcemia causes in their loved one's thinking and behavior.
Patients and caregivers should learn the signs of hypercalcemia.
Hypercalcemia can affect your quality of life and be life threatening if not treated right away. You and your caregiver should learn the symptoms to look for and report them to your doctor as soon as they occur. Staying active and drinking plenty of fluids will help prevent hypercalcemia. See the Symptoms of Hypercalcemia section for hypercalcemia symptoms.
Check NCI's list of cancer clinical trials for U.S. supportive and palliative care trials about hypercalcemia of malignancy that are now accepting participants. The list of trials can be further narrowed by location, drug, intervention, and other criteria.
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
This summary was completely reformatted and some content was added.
Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in Spanish.
PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government's center of biomedical research. The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.
Purpose of This Summary
This PDQ cancer information summary has current information about the pathophysiology and treatment of hypercalcemia. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.
Reviewers and Updates
Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Date Last Modified") is the date of the most recent change.
The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the PDQ Supportive and Palliative Care Editorial Board.
Clinical Trial Information
A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Clinical trials are listed in PDQ and can be found online at NCI's Web site. Many cancer doctors who take part in clinical trials are also listed in PDQ. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237).
Permission to Use This Summary
PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as "NCI's PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary]."
The best way to cite this PDQ summary is:
National Cancer Institute: PDQ® Hypercalcemia. Bethesda, MD: National Cancer Institute. Date last modified <MM/DD/YYYY>. Available at: http://cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/Patient. Accessed <MM/DD/YYYY>.
Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in Visuals Online. Visuals Online is a collection of more than 2,000 scientific images.
The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the Coping with Cancer: Financial, Insurance, and Legal Information page.
More information about contacting us or receiving help with the Cancer.gov Web site can be found on our Contact Us for Help page. Questions can also be submitted to Cancer.gov through the Web site's Contact Form.
If you have questions or comments about this summary, please send them to Cancer.gov through the Web site's Contact Form. We can respond only to email messages written in English.
For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.
The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer.
Write to us
For more information from the NCI, please write to this address:
Search the NCI Web site
The NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support and resources for cancer patients and their families. For a quick search, use the search box in the upper right corner of each Web page. The results for a wide range of search terms will include a list of "Best Bets," editorially chosen Web pages that are most closely related to the search term entered.
There are also many other places to get materials and information about cancer treatment and services. Hospitals in your area may have information about local and regional agencies that have information on finances, getting to and from treatment, receiving care at home, and dealing with problems related to cancer treatment.
The NCI has booklets and other materials for patients, health professionals, and the public. These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials. Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities. NCI materials on these and other topics may be ordered online or printed directly from the NCI Publications Locator. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237).
Last Revised: 2012-11-09
If you want to know more about cancer and how it is treated, or if you wish to know about clinical trials for your type of cancer, you can call the NCI's Cancer Information Service at 1-800-422-6237, toll free. A trained information specialist can talk with you and answer your questions.
How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.